At a glance
Moderna and Merck's mRNA melanoma vaccine, intismeran autogene, succeeded in a late-stage trial announced August 19–20, 2026. The underlying mRNA science traces to Katalin Karikó, a Hungarian immigrant and 2023 Nobel laureate. Moderna was co-founded by Noubar...